In the univariate analysis, tumor size ≥2 cm, metastatic lymph nodes ≥6, metastatic lymph node ratio ≥0.2 and AURKAhigh/TILslow were associated with an increased risk of BCR in patients with MTC. The gene discussed is BCR; the disease is neoplasm.